Kanabo Group PLC - medical cannabis research and development - Pretax loss in six months to June 30 widens to GBP2.4 million from GBP344,000 year before. Revenue flat year on year at GBP15,000 from GBP14,000. Research expenses rise to GBP116,000 from GBP75,000 and general & administrative expenses increase to GBP888,000 from GBP200,000.
"This has been an exciting half year for Kanabo," Chair David Tsur says.
Continues: "The board remains committed to executing our strategy of leading the global evolution of the cannabis industry by building an integrated platform that will generate value from new product development through to production and distribution."
Current stock price: 16.22 pence
Year-to-date change: down 12% since reverse takeover in February
By Paul McGowan; paulmcgowan@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.